Hypoglycemia is known to upregulate SLC2A1 [71] and SLC2A3 [72], optimizing glucose uptake when blood glucose levels are low, further supporting the observed response in the RES treatment. This evidence concerns the gene SLC2A3 and Hypoglycemia.